Potential offtaker

Aragen Life Sciences Private Limited

www.aragen.com

Estimated electricity consumption

N/A

Countries of production presence

N/A

Aragen Life Sciences Private Limited is a leading contract research organization (CRO) based in India, with a global presence. The company provides a wide range of services to pharmaceutical and biotech companies, including drug discovery, development, and manufacturing. Aragen has a strong focus on innovation and sustainability, which is reflected in its commitment to decarbonisation and renewable energy.

Decarbonisation is a key priority for Aragen, as the company recognizes the urgent need to reduce greenhouse gas emissions and mitigate the impacts of climate change. To achieve this goal, Aragen has implemented a number of initiatives to reduce its carbon footprint and promote sustainable practices. For example, the company has invested in energy-efficient technologies and processes, such as LED lighting and HVAC systems, to reduce its energy consumption and carbon emissions. Aragen has also implemented a waste management program to reduce the amount of waste generated by its operations, and to ensure that any waste generated is disposed of in an environmentally responsible manner.

Corporate energy is another area of focus for Aragen, as the company recognizes the importance of managing its energy use and costs. To achieve this goal, Aragen has implemented a number of measures to optimize its energy use and reduce its energy costs. For example, the company has implemented an energy management system to monitor and control its energy use, and has conducted energy audits to identify areas where energy efficiency improvements can be made. Aragen has also implemented a number of energy-saving measures, such as installing energy-efficient lighting and HVAC systems, and using renewable energy sources where possible.

Corporate power purchase agreements (PPAs) are an important tool for Aragen to achieve its renewable energy goals. A PPA is a contract between a renewable energy provider and a corporate buyer, in which the buyer agrees to purchase a certain amount of renewable energy from the provider over a specified period of time. Aragen has entered into several PPAs with renewable energy providers, which has enabled the company to purchase renewable energy at a fixed price and reduce its reliance on fossil fuels. Aragen has also invested in on-site renewable energy generation, such as solar panels, to further reduce its carbon footprint and energy costs.

Renewable energy is a key focus for Aragen, as the company recognizes the importance of transitioning to a low-carbon economy. To achieve this goal, Aragen has implemented a number of initiatives to increase its use of renewable energy. For example, the company has invested in on-site renewable energy generation, such as solar panels, to reduce its reliance on fossil fuels. Aragen has also entered into several corporate PPAs with renewable energy providers, which has enabled the company to purchase renewable energy at a fixed price and reduce its carbon footprint. In addition, Aragen has implemented energy-saving measures, such as energy-efficient lighting and HVAC systems, to reduce its energy consumption and carbon emissions.

In conclusion, Aragen Life Sciences Private Limited is a leading contract research organization based in India, with a strong focus on innovation and sustainability. The company is committed to decarbonisation and renewable energy, and has implemented a number of initiatives to reduce its carbon footprint and promote sustainable practices. Aragen has invested in energy-efficient technologies and processes, implemented a waste management program, and entered into corporate PPAs with renewable energy providers. The company has also invested in on-site renewable energy generation, such as solar panels, and implemented energy-saving measures to reduce its energy consumption and carbon emissions. Aragen's commitment to sustainability is a testament to its leadership and vision, and sets an example for other companies in the contract research sector.